SOLSTICE ADV MATERIALS INC (SOLS) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:SOLS • US83443Q1031

64.79 USD
+1.37 (+2.16%)
At close: Feb 6, 2026
65.38 USD
+0.59 (+0.91%)
After Hours: 2/6/2026, 8:06:44 PM
Fundamental Rating

4

Overall SOLS gets a fundamental rating of 4 out of 10. We evaluated SOLS against 83 industry peers in the Chemicals industry. SOLS scores excellent on profitability, but there are concerns on its financial health. SOLS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • SOLS had positive earnings in the past year.
  • The reported net income has been mixed in the past 5 years: SOLS reported negative net income in multiple years.
  • In multiple years SOLS reported negative operating cash flow during the last 5 years.
SOLS Yearly Net Income VS EBIT VS OCF VS FCFSOLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

1.2 Ratios

  • SOLS's Return On Assets of 11.32% is amongst the best of the industry. SOLS outperforms 96.39% of its industry peers.
  • SOLS has a better Return On Equity (18.40%) than 87.95% of its industry peers.
  • SOLS has a Return On Invested Capital of 15.55%. This is amongst the best in the industry. SOLS outperforms 95.18% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for SOLS is significantly above the industry average of 6.08%.
  • The last Return On Invested Capital (15.55%) for SOLS is well below the 3 year average (19277.20%), which needs to be investigated, but indicates that SOLS had better years and this may not be a problem.
Industry RankSector Rank
ROA 11.32%
ROE 18.4%
ROIC 15.55%
ROA(3y)7294.93%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)19277.2%
ROIC(5y)N/A
SOLS Yearly ROA, ROE, ROICSOLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 20K -20K 40K

1.3 Margins

  • The Profit Margin of SOLS (15.76%) is better than 95.18% of its industry peers.
  • SOLS's Operating Margin of 21.83% is amongst the best of the industry. SOLS outperforms 89.16% of its industry peers.
  • SOLS has a Gross Margin of 34.64%. This is in the better half of the industry: SOLS outperforms 69.88% of its industry peers.
Industry RankSector Rank
OM 21.83%
PM (TTM) 15.76%
GM 34.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SOLS Yearly Profit, Operating, Gross MarginsSOLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

3

2. Health

2.1 Basic Checks

  • SOLS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • The number of shares outstanding for SOLS remains at a similar level compared to 1 year ago.
  • SOLS has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for SOLS is higher compared to a year ago.
SOLS Yearly Shares OutstandingSOLS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
SOLS Yearly Total Debt VS Total AssetsSOLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

  • A Debt/Equity ratio of 0.13 indicates that SOLS is not too dependend on debt financing.
  • The Debt to Equity ratio of SOLS (0.13) is better than 84.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC1
WACC15.53%
SOLS Yearly LT Debt VS Equity VS FCFSOLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

  • SOLS has a Current Ratio of 1.53. This is a normal value and indicates that SOLS is financially healthy and should not expect problems in meeting its short term obligations.
  • SOLS has a Current ratio of 1.53. This is in the lower half of the industry: SOLS underperforms 68.67% of its industry peers.
  • SOLS has a Quick Ratio of 1.53. This is a bad value and indicates that SOLS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • SOLS's Quick ratio of 0.93 is on the low side compared to the rest of the industry. SOLS is outperformed by 65.06% of its industry peers.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 0.93
SOLS Yearly Current Assets VS Current LiabilitesSOLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

3

3. Growth

3.1 Past

  • The earnings per share for SOLS have decreased by -4.35% in the last year.
  • Looking at the last year, SOLS shows a small growth in Revenue. The Revenue has grown by 3.32% in the last year.
  • The Revenue has been growing by 2650.90% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-4.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)3.32%
Revenue growth 3Y2650.9%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • SOLS is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -3.40% yearly.
  • SOLS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.77% yearly.
EPS Next Y-48.49%
EPS Next 2Y-10.68%
EPS Next 3Y-3.4%
EPS Next 5YN/A
Revenue Next Year3.21%
Revenue Next 2Y3.45%
Revenue Next 3Y3.77%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SOLS Yearly Revenue VS EstimatesSOLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
SOLS Yearly EPS VS EstimatesSOLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 17.32, which indicates a rather expensive current valuation of SOLS.
  • 63.86% of the companies in the same industry are more expensive than SOLS, based on the Price/Earnings ratio.
  • SOLS is valuated rather cheaply when we compare the Price/Earnings ratio to 27.93, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 21.70, which indicates a rather expensive current valuation of SOLS.
  • The rest of the industry has a similar Price/Forward Earnings ratio as SOLS.
  • The average S&P500 Price/Forward Earnings ratio is at 27.77. SOLS is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 17.32
Fwd PE 21.7
SOLS Price Earnings VS Forward Price EarningsSOLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 61.45% of the companies in the same industry are more expensive than SOLS, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.9
SOLS Per share dataSOLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • SOLS has a very decent profitability rating, which may justify a higher PE ratio.
  • A cheap valuation may be justified as SOLS's earnings are expected to decrease with -3.40% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-10.68%
EPS Next 3Y-3.4%

0

5. Dividend

5.1 Amount

  • No dividends for SOLS!.
Industry RankSector Rank
Dividend Yield 0%

SOLSTICE ADV MATERIALS INC

NASDAQ:SOLS (2/6/2026, 8:06:44 PM)

After market: 65.38 +0.59 (+0.91%)

64.79

+1.37 (+2.16%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-06
Earnings (Next)02-11
Inst Owners25.13%
Inst Owner Change1517730000%
Ins Owners0%
Ins Owner Change-5205870%
Market Cap10.28B
Revenue(TTM)3.77B
Net Income(TTM)594.00M
Analysts76.36
Price Target67.34 (3.94%)
Short Float %1.72%
Short Ratio0.84
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)14.22%
PT rev (3m)N/A
EPS NQ rev (1m)-1.02%
EPS NQ rev (3m)-10.69%
EPS NY rev (1m)-4.91%
EPS NY rev (3m)-23.48%
Revenue NQ rev (1m)0.25%
Revenue NQ rev (3m)1.29%
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)9.39%
Valuation
Industry RankSector Rank
PE 17.32
Fwd PE 21.7
P/S 2.73
P/FCF N/A
P/OCF N/A
P/B 3.19
P/tB 4.34
EV/EBITDA 9.9
EPS(TTM)3.74
EY5.77%
EPS(NY)2.99
Fwd EY4.61%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS23.75
BVpS20.34
TBVpS14.92
PEG (NY)N/A
PEG (5Y)N/A
Graham Number41.37
Profitability
Industry RankSector Rank
ROA 11.32%
ROE 18.4%
ROCE 20.47%
ROIC 15.55%
ROICexc 17.35%
ROICexgc 22.78%
OM 21.83%
PM (TTM) 15.76%
GM 34.64%
FCFM N/A
ROA(3y)7294.93%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)19277.2%
ROIC(5y)N/A
ROICexc(3y)54278.7%
ROICexc(5y)N/A
ROICexgc(3y)54283.9%
ROICexgc(5y)N/A
ROCE(3y)-199689%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA 0.4
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.53
Quick Ratio 0.93
Altman-Z N/A
F-ScoreN/A
WACC15.53%
ROIC/WACC1
Cap/Depr(3y)145.9%
Cap/Depr(5y)N/A
Cap/Sales(3y)7.71%
Cap/Sales(5y)N/A
Profit Quality(3y)78.83%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-48.49%
EPS Next 2Y-10.68%
EPS Next 3Y-3.4%
EPS Next 5YN/A
Revenue 1Y (TTM)3.32%
Revenue growth 3Y2650.9%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year3.21%
Revenue Next 2Y3.45%
Revenue Next 3Y3.77%
Revenue Next 5YN/A
EBIT growth 1Y0%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year18.12%
EBIT Next 3Y11.05%
EBIT Next 5YN/A
FCF growth 1Y18.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y10.79%
OCF growth 3YN/A
OCF growth 5YN/A

SOLSTICE ADV MATERIALS INC / SOLS FAQ

What is the fundamental rating for SOLS stock?

ChartMill assigns a fundamental rating of 4 / 10 to SOLS.


What is the valuation status of SOLSTICE ADV MATERIALS INC (SOLS) stock?

ChartMill assigns a valuation rating of 3 / 10 to SOLSTICE ADV MATERIALS INC (SOLS). This can be considered as Overvalued.


How profitable is SOLSTICE ADV MATERIALS INC (SOLS) stock?

SOLSTICE ADV MATERIALS INC (SOLS) has a profitability rating of 7 / 10.


How financially healthy is SOLSTICE ADV MATERIALS INC?

The financial health rating of SOLSTICE ADV MATERIALS INC (SOLS) is 3 / 10.


What is the expected EPS growth for SOLSTICE ADV MATERIALS INC (SOLS) stock?

The Earnings per Share (EPS) of SOLSTICE ADV MATERIALS INC (SOLS) is expected to decline by -48.49% in the next year.